Effects of naproxen and sulphasalazine or methotrexate on hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis

Clinical and Experimental Rheumatology

Volumn 29, Issue 1, 2011, Pages 35-42

  Eijsbouts, Agnes M M ^a   Kempers, Marlies J E ^b   van den Hoogen, Frank H J ^a   Laan, Roland F J M ^b   Hermus, Ad R M M ^b   Ross, H Alec ^b   Sweep, Fred C G J ^b   van de Putte, Leo B A ^b  

^a Sint Maartenskliniek   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Hypothalamic pituitary unit; Non steroidal anti inflammatory agents; Pituitary adrenal system; Rheumatoid arthritis

Indexed keywords

CORTICOTROPIN; HORMONE BINDING PROTEIN; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; METHOTREXATE; NAPROXEN; SALAZOSULFAPYRIDINE; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE; DIAGNOSTIC AGENT; INSULIN; NONSTEROID ANTIINFLAMMATORY AGENT;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE ACTIVITY; FEMALE; HORMONE DETERMINATION; HORMONE INHIBITION; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE URINE LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN TOLERANCE TEST; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RHEUMATOID ARTHRITIS; SALIVA LEVEL; SIDE EFFECT; BLOOD; DRUG COMBINATION; DRUG EFFECT; GLUCOSE BLOOD LEVEL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENOCORTICOTROPIC HORMONE; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ARTHRITIS, RHEUMATOID; BLOOD GLUCOSE; CYTOKINES; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; INSULIN; MALE; METHOTREXATE; NAPROXEN; PITUITARY-ADRENAL SYSTEM; SULFASALAZINE;

EID: 79955671005     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. STRAUB RH, CUTOLO M: Involvement of the hypothalamic--pituitary--adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum 2001; 44: 493-507.
2. JESSOP DS, HARBUZ MS: A defect in cortisol production in rheumatoid arthritis: why are we still looking? Rheumatology 2005; 44: 1097-100
3. EIJSBOUTS AM, VAN DEN HOOGEN FH, LAAN RF, HERMUS AR, SWEEP CG, VAN DE PUTTE LB: Hypothalamic-pituitary-adrenal axis activity in patients with rheumatoid arthritis. Clin Exp Rheumatol 2005; 23: 658-64.
4. PERRY MG, KIRWAN JR, JESSOP DS, HUNT LP. Overnight variations in cortisol, interleukin 6, tumour necrosis factor alpha and other cytokines in people with rheumatoid arthritis. Ann Rheum Dis 2009; 68: 63-8.
5. BESEDOVSKY HO, DEL RA: Immune-neuroendocrine interactions: facts and hypotheses. Endocr Rev 1996; 17: 64-102.
6. EIJSBOUTS AM, MURPHY EP: The role of the hypothalamic-pituitary-adrenal axis in rheumatoid arthritis. Baillieres Best Pract Res Clin Rheumatol 1999; 13: 599-613.
7. HALL J, MORAND EF, MEDBAK S et al.: Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion. Arthritis Rheum 1994; 37: 1132-7.
8. STRAUB RH, HARLE P, SARZI-PUTTINI P, CUTOLO M: Tumor necrosis factor-neutralizing therapies improve altered hormone axes: an alternative mode of antiinflammatory action. Arthritis Rheum 2006; 54: 2039-46.
9. SILVERMAN MN, PEARCE BD, BIRON CA, MILLER AH: Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection. Viral Immunol 2005; 18: 41-78.
10. MARX C, EHRHART-BORNSTEIN M, SCHERBAUM WA, BORNSTEIN SR: Regulation of adrenocortical function by cytokines--relevance for immune-endocrine interaction. Horm Metab Res 1998; 30: 416-20.
11. KATSUURA G, GOTTSCHALL PE, DAHL RR, ARIMURA A: Adrenocorticotropin release induced by intracerebroventricular injection of recombinant human interleukin-1 in rats: possible involvement of prostaglandin. Endocrinology 1988; 122: 1773-9.
12. RIVIER C, VALE W: Stimulatory effect of interleukin-1 on adrenocorticotropin secretion in the rat: is it modulated by prostaglandins? Endocrinology 1991; 129: 384-8
13. NAVARRA P, TSAGARAKIS S, FARIA MS, REES LH, BESSER GM, GROSSMAN AB: Interleukins-1 and -6 stimulate the release of corticotropin-releasing hormone-41 from rat hypothalamus in vitro via the eicosanoid cyclooxygenase pathway. Endocrinology 1991; 128: 37-44.
14. PARSADANIANTZ SM, LEBEAU A, DUVAL P, GRIMALDI B, TERLAIN B, KERDELHUE B: Effects of the inhibition of cyclo-oxygenase 1 or 2 or 5-lipoxygenase on the activation of the hypothalamic-pituitary-adrenal axis induced by interleukin-1beta in the male Rat J Neuroendocrinol 2000; 12: 766-73
15. ARNETT FC, EDWORTHY SM, BLOCH DA et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315-24.
16. VAN DER HEIJDE DM, VAN'T HOF MA, VAN RIEL PL et al.: Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score. Ann Rheum Dis 1990; 49: 916-20.
17. SMALS AG, KLOPPENBORG PW, GOVERDE HJ, BENRAAD TJ: The effect of cyproterone acetate on the pituitary-adrenal axis in hirsute women. Acta Endocrinol (Copenh) 1978; 87: 352-8.
18. SWINKELS LM, MEULENBERG PM, ROSS HA, BENRAAD TJ: Salivary and plasma free testosterone and androstenedione levels in women using oral contraceptives containing desogestrel or levonorgestrel. Ann Clin Biochem 1988; 25 (Pt 4): 354-9.
19. MEULENBERG PM, ROSS HA, SWINKELS LM, BENRAAD TJ: The effect of oral contraceptives on plasma-free and salivary cortisol and cortisone. Clin Chim Acta 1987; 165: 379-85.
20. DRENTH JP, VAN UUM SH, VAN DM, PESMAN GJ, VAN D, V, VAN DER MEER JW: Endurance run increases circulating IL-6 and IL-1ra but downregulates ex vivo TNF-alpha and IL-1 beta production. J Appl Physiol 1995; 79: 1497-503.
21. HOCKINGS GI, GRICE JE, CROSBIE GV, WALTERS MM, JACKSON AJ, JACKSON RV: Aspirin increases the human hypothalamicpituitary-adrenal axis response to naloxone stimulation. J Clin Endocrinol Metab 1993; 77: 404-8.
22. BEIRNE J, JUBIZ W: Effect of indomethacin on the hypothalamic-pituitary-adrenal axis in man. J Clin Endocrinol Metab 1978; 47: 713-6.
23. EIJSBOUTS AM, KEMPERS MJ, KRAMER RS et al.: Effect of naproxen on the hypothalamicpituitary-adrenal axis in healthy volunteers. British Journal of Clinical Pharmacology 2009; 67: 22-8.
24. HALTER JB, METZ SA: Sodium salicylate augments the plasma adrenocorticotropin and cortisol responses to insulin hypoglycemia in man. J Clin Endocrinol Metab 1982; 54: 127-20.
25. CAVAGNINI F, DI LANDRO A, MARASCHINI C, INVITTI C, PINTO ML: Effect of two prostaglandin synthesis inhibitors, indomethacinand acetylsalicylic acid, on plasma ACTH and cortisol levels in man. Acta Endocrinol (Copenh) 1979; 91: 666-73.
26. DI LUIGI L, ROSSI C, SGRO P et al.: Do nonsteroidal anti-inflammatory drugs influence the steroid hormone milieu in male athletes? Int J Sports Med 2007; 28: 809-14.
27. ZACHARIEVA S, WIPPERMANN M, MUCHA I, ANDONOVA K, JANKOVA G: Indomethacin and meclofenamate do not alter ACTH and cortisol responses to corticotropin-releasing hormone (CRH) in normal subjects. Clin Physiol Biochem 1993; 10: 28-32.
28. NYE EJ, HOCKINGS GI, GRICE JE et al.: Aspirin inhibits vasopressin-induced hypothalamic-pituitary-adrenal activity in normal humans. J Clin Endocrinol Metab 1997; 82: 812-7.
29. DI LUIGI L, GUIDETTI L, ROMANELLI F, BALDARI C, CONTE D: Acetylsalicylic acid inhibits the pituitary response to exercise-related stress in humans. Med Sci Sports Exerc 2001; 33: 2029-35.
30. DAZA L, MARTIN-JIMENEZ R, DE LA TORRE PX, HERNANDEZ E, MURILLO B: Improvement of ACTH response to insulin tolerance test in female patients with rheumatoid arthritis due to tumor necrosis factor inhibition. Eur J Endocrinol 2007; 157: 47-51.
31. ATZENI F, SARZI-PUTTINI P, DE PORTU S, CUTOLO M, CARRABBA M, STRAUB RH: In etanercept-treated psoriatic arthritis patients clinical improvement correlated with an increase of serum cortisol relative to other adrenal hormones. Clin Exp Rheumatol 2008; 26: 103-8.